Desipramine in Infantile Neuroaxonal Dystrophy (INAD).
Novel Off-label Use of Desipramine in Infantile Neuroaxonal Dystrophy: Targeting the Sphingolipid Metabolism Pathway to Reduce Accumulation of Ceramide. Novel Off-label Use of Desipraminein Infantile Neuroaxonal Dystrophy: Targeting the Sphingolipid Met ...